oncology

Drug development is producing more data than ever, and large pharmaceutical companies like AstraZeneca are turning to AI to make sense of it. The challenge is no longer whether AI can help, but how tightly it needs to be built into research and clinical work to improve decisions around trials and treatment. That question helps…